NASDAQ · XMTR
Xometry, Inc.
$100.82+$1.07 (+1.07%)
Xometry, Inc.’s quoted price sits in the upper half of its reported 52-week range, 10.73% below the high.
Loading market information…
NASDAQ · MTLS · USD
Stock price, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Materialise N.V.’s quoted price sits in the upper half of its reported 52-week range, 17.91% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Materialise N.V.’s next earnings report is currently expected on Feb 18, 2027, with estimated earnings per share of $0.06. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Materialise N.V.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Materialise N.V. (MTLS), founded in 1990 and headquartered in Leuven, Belgium, is a global leader in additive manufacturing and medical technology. The company offers specialized software and comprehensive 3D printing services across the Americas, Europe, Africa, and Asia-Pacific regions. Its operations are divided into three core segments: 1. Materialise Software: This division develops sophisticated software solutions designed to empower and optimize the functionality of 3D printers and overall 3D printing workflows. Their software acts as a vital bridge, connecting various types of 3D printers with different software applications and data capture technologies, such as computer-aided design/manufacturing suites and 3D scanners. This segment serves a diverse clientele, including manufacturers of 3D printing equipment, production companies, and contract manufacturers in industries like automotive, aerospace, consumer goods, and hearing aids, as well as 3D printing service bureaus. Sales are conducted through their dedicated sales force, online platform, and a network of third-party distributors. 2. Materialise Medical: Focused on healthcare, this segment provides medical software that facilitates advanced medical-image-based analysis and engineering. This capability supports the personalized design of surgical devices and implants tailored to individual patients. Its customer base includes medical device companies, hospitals, universities, research institutions, and industrial firms, with sales handled by a direct sales team, their website, and through partnerships with picture archiving and communication system (PACS) providers. 3. Materialise Manufacturing: This segment delivers end-to-end 3D printing services. It encompasses design and engineering support, rapid prototyping, and the additive manufacturing of final production parts for a broad spectrum of industrial and commercial clients. Materialise N.V. also maintains significant collaboration agreements with several prominent companies in the medical field, including Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 29, 2026, 10:55 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q2 2025 | Jul 24, 2025 | $0.00-60.3% vs estimate | $76.33M+13.46% vs estimate |
|---|
| Q1 2025 | Apr 24, 2025 | -$0.01-150.0% vs estimate | $72.77M+8.28% vs estimate |
|---|
| Q4 2024 | Feb 20, 2025 | $0.050.0% vs estimate | $68.01M+7.78% vs estimate |
|---|
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
THE ANALYST VIEW
12 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
Percentages compare targets with the quoted price when currencies match. Targets are analyst estimates, not guaranteed outcomes.
Average targets in published notes for each window. These figures use a different sample from the consensus above.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$100.82+$1.07 (+1.07%)
Xometry, Inc.’s quoted price sits in the upper half of its reported 52-week range, 10.73% below the high.
€57.50+€0.45 (+0.79%)
Melexis N.V.’s quoted price sits in the lower half of its reported 52-week range, 33.68% below the high.
$77.64-$13.27 (-14.6%)
Proto Labs, Inc.’s quoted price sits in the upper half of its reported 52-week range, 22.33% below the high.
€5.56+€0.11 (+1.92%)
X-FAB Silicon Foundries SE’s quoted price sits in the lower half of its reported 52-week range, 64.99% below the high.
$7.03-$0.12 (-1.68%)
Stratasys Ltd.’s quoted price sits in the lower half of its reported 52-week range, 42.57% below the high.
€6.49-€0.07 (-1.07%)
Barco N.V.’s quoted price sits in the lower half of its reported 52-week range, 48.82% below the high.
$2.93-$0.06 (-2.01%)
3D Systems Corporation’s quoted price sits in the upper half of its reported 52-week range, 28.88% below the high.
$7.07+$0.08 (+1.14%)
Velo3D, Inc.’s quoted price sits in the lower half of its reported 52-week range, 77.73% below the high.
